10x Genomics, Inc. SEC filings TXG

10x Genomics, Inc. has 696 filings in SEC EDGAR's recent list, going back to May 9, 2019. Its latest annual report, Form 10-K, was filed on Feb 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

10x Genomics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Feb 13, 2026 —
S-8 Employee stock plan registration Feb 13, 2025 —
S-8 Employee stock plan registration Feb 15, 2024 —
S-8 Employee stock plan registration Feb 16, 2023 —
S-8 Employee stock plan registration Feb 18, 2022 —
S-8 Employee stock plan registration Mar 1, 2021 —
S-3ASR Automatic shelf registration Oct 16, 2020 —
424B4 Prospectus Sep 11, 2020 —
S-1MEF Filing Sep 10, 2020 —
S-1 Registration statement Sep 8, 2020 —
424B3 Prospectus Sep 27, 2019 —
S-8 Employee stock plan registration Sep 12, 2019 —
424B4 Prospectus Sep 12, 2019 —
FWP Free writing prospectus Sep 12, 2019 —
S-1MEF Filing Sep 11, 2019 —
S-1/A Amended registration statement Sep 10, 2019 —
S-1/A Amended registration statement Sep 3, 2019 —
S-1 Registration statement Aug 19, 2019 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
TXG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Pleasanton, CA
SEC filer status
Large accelerated filer
SEC CIK
1770787

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.